IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,170 | -99.0% | 11,920 | -98.8% | 0.00% | -100.0% |
| Q2 2023 | $19,484,766 | +4838.3% | 1,032,579 | +904.9% | 0.04% | +4200.0% |
| Q1 2023 | $394,564 | -79.4% | 102,751 | -73.4% | 0.00% | -80.0% |
| Q4 2022 | $1,918,498 | +289.1% | 386,794 | +252.5% | 0.01% | +150.0% |
| Q2 2022 | $493,000 | -61.0% | 109,741 | -42.8% | 0.00% | -66.7% |
| Q2 2021 | $1,264,000 | +8.4% | 191,876 | -55.4% | 0.01% | -25.0% |
| Q1 2019 | $1,166,000 | -4.0% | 430,328 | +70.0% | 0.01% | -11.1% |
| Q4 2018 | $1,215,000 | -91.2% | 253,085 | -80.8% | 0.01% | -84.5% |
| Q1 2018 | $13,866,000 | +8566.2% | 1,318,023 | +5176.7% | 0.06% | – |
| Q4 2017 | $160,000 | +135.3% | 24,978 | +12.4% | 0.00% | – |
| Q2 2016 | $68,000 | – | 22,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
| QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
| Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
| Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
| PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
| Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
| Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
| DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
| DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |